Conformable GORE TAG Thoracic Endoprosthesis
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $183,546 | 65 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $183,546 | 65 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Evaluation of the Conformable GORE TAG Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection | W. L. Gore & Associates, Inc. | $69,625 | 0 |
| An Evaluation of the Conformable GORE TAG Thoracic Endoprosthesis for the Primary Treatment of Aneurysm of the Descending Thoracic Aorta | W. L. Gore & Associates, Inc. | $65,267 | 0 |
| Evaluation of the Conformable GORE TAG Thoracic Endoprosthesis for Treatment of Traumatic Transection of the Descending Thoracic Aorta | W. L. Gore & Associates, Inc. | $48,654 | 0 |
Top Doctors Receiving Payments for Conformable GORE TAG Thoracic Endoprosthesis
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Tampa, FL | $183,546 | 65 |
Manufacturing Companies
- W. L. Gore & Associates, Inc. $183,546
Product Information
- Type Device
- Total Payments $183,546
- Total Doctors 0
- Transactions 65
About Conformable GORE TAG Thoracic Endoprosthesis
Conformable GORE TAG Thoracic Endoprosthesis is a device associated with $183,546 in payments to 0 healthcare providers, recorded across 65 transactions in the CMS Open Payments database. The primary manufacturer is W. L. Gore & Associates, Inc..
Payment data is available from 2017 to 2017. In 2017, $183,546 was paid across 65 transactions to 0 doctors.
The most common payment nature for Conformable GORE TAG Thoracic Endoprosthesis is "Unspecified" ($183,546, 100.0% of total).
Conformable GORE TAG Thoracic Endoprosthesis is associated with 3 research studies, including "Evaluation of the Conformable GORE TAG Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection" ($69,625).